Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-17-001469

Options or other derivatives

  • PRESIDENT AND CEO acquired 243,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DAVIS STEPHEN PRESIDENT AND CEO 2017-09-07 Grant or award · Stock Option (right to buy) +243,750 243,750 D
Loading xslF345X03/form4-09082017_030906.xml…